Vitamin e antioxydants



Trial Studied treatment Control Patients Size Study type Results NCT

Cardiovascular prevention - antioxydants in all type of patients - antioxydants in primary prevention - antioxydants in secondary prevention - antioxydants in patients with renal disease

GISSI, 1999vitamin Econtrol11324 (5660/5664) Confirmatory -
PPP, 2001vitamin Econtrol4495 (2231/2264) Confirmatory -
CHAOS, 1996vitamin Eplacebo2002 (1035/967) Exploratory
SPACE, 2000vitamin Eplacebo196 (97/99) Confirmatory
HOPE, 2000vitamin Eplacebo9541 (4761/4780) Confirmatory
ATBC vitamin E, 1994vitamin Eplacebo29133 (14564/14569) Exploratory
WACS vitamin E, 2007vitamin Eplacebo8171 (4083/4088) Confirmatory NCT00000541
WHS vitamin E, 2005vitamin Eplacebo39876 (19937/19939) Exploratory NCT00000479
PHS II vitamin E, 2008vitamin Eplacebo14641 (7315/7326) Confirmatory NCT00270647
HOPE renal insufficiency subgroup, 2004vitamin Eplacebo993 (499/494) Exploratory
ASAP, 2000vitamin Eplacebo520 (260/260) Exploratory
ATBC 2nd prev subgroup (vitamin E), 1998vitamin Eplacebo1795 (916/879) Exploratory
AREDS, 2001vitamin Eplacebo4757 (2370/2387) Exploratory
Linxian, 1993vitamin Eplacebo29584 (14792/14792)

Peripheral vascular diseases - antioxydants in all type of patients

Hamilton, 1953placebo41 (20/21)
Livingstone, 1958placebo40 (20/20)